Skip to main content
logo
Sutro Biopharma, Inc. (FRA:S090)
Germany flag Germany · Delayed Price · Currency is EUR
12.50
-0.50 (-3.85%)
At close: Jan 23, 2026

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Site-specific and Novel-format Antibody Drug Conjugates
153.73M
Site-specific and Novel-format Antibody Drug Conjugates Growth
126.84%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
153.73M
United States Growth
126.84%